Hongbing Ma
-
- Cancer-related Molecular Pathways 3
-
- RNA modifications and cancer 5
- Epigenetics and DNA Methylation 4
- PI3K/AKT/mTOR signaling in cancer 3
-
- Ferroptosis and cancer prognosis 4
- Gastric Cancer Management and Outcomes 4
- Lung Cancer Diagnosis and Treatment 3
-
- Esophageal Cancer Research and Treatment 5
- Journals
- Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (1 paper)Scientific Reports (1 paper)
In The Last Decade
Hongbing Ma
33 papers receiving 398 citations
Peers
Comparison fields: 5 of 70
- Cancer Research 103
- Oncology 89
- Molecular Biology 200
- Pulmonary and Respiratory Medicine 80
- Pharmacology 18
Countries citing papers authored by Hongbing Ma
This map shows the geographic impact of Hongbing Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongbing Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongbing Ma more than expected).
Fields of papers citing papers by Hongbing Ma
This network shows the impact of papers produced by Hongbing Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongbing Ma. The network helps show where Hongbing Ma may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hongbing Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 6 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 21 | |
| 5 | 2022 | 1 | |
| 6 | 2022 | 15 | |
| 7 | 2022 | 0 | |
| 8 | 2021 | 16 | |
| 9 | 2021 | 10 | |
| 10 | 2019 | 28 | |
| 11 | 2019 | 2 | |
| 12 | 2016 | 13 | |
| 13 | 2015 | 8 | |
| 14 | 2014 | 5 | |
| 15 | 2014 | 21 | |
| 16 | 2014 | 27 | |
| 17 | 2014 | 31 | |
| 18 | 2014 | 28 | |
| 19 | 2005 | 18 | |
| 20 | 2004 | 14 |
About Hongbing Ma
Hongbing Ma is a scholar working on Aging, Cancer Research and Oncology, having authored 36 papers that have together received 405 indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (5 papers), RNA modifications and cancer (5 papers), Ferroptosis and cancer prognosis (4 papers), Gastric Cancer Management and Outcomes (4 papers), Epigenetics and DNA Methylation (4 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Lung Cancer Diagnosis and Treatment (3 papers) and Cancer-related Molecular Pathways (3 papers). The work is most often cited by research in Cancer Research (103 citations), Oncology (89 citations) and Molecular Biology (200 citations). Hongbing Ma has collaborated with scholars based in China, Finland and Taiwan. Frequent co-authors include Xi-Jing Wang, Xiaoxiao Liu, Xiaozhi Zhang, Shuai Lin, Hong Duan, Shuqun Zhang, Yong Zeng, Shenli Tang, Zongfang Li and Pengtao Yang. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.